These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1428731)

  • 1. A phase II study of interleukin-2 and interferon-alpha in head and neck cancer.
    Schantz SP; Dimery I; Lippman SM; Clayman GL; Pellegrino C; Morice R
    Invest New Drugs; 1992 Aug; 10(3):217-23. PubMed ID: 1428731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of interferon-alpha in locally recurrent or metastatic squamous cell carcinoma of the head and neck: immunological and clinical correlates.
    Vlock DR; Andersen J; Kalish LA; Johnson JT; Kirkwood JM; Whiteside T; Herberman RB; Adams GS; Oken MM; Haselow RE
    J Immunother Emphasis Tumor Immunol; 1996 Nov; 19(6):433-42. PubMed ID: 9041463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.
    Bergmann L; Fenchel K; Weidmann E; Enzinger HM; Jahn B; Jonas D; Mitrou PS
    Cancer; 1993 Sep; 72(5):1733-42. PubMed ID: 8348502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute-phase proteins in patients with head and neck cancer treated with interleukin 2/interferon alfa.
    Clayman GL; Liu FJ; Savage HE; Taylor DL; Lavedan P; Buchsbaum RM; Pellegrino C; Trujillo JM; Young G; Schantz SP
    Arch Otolaryngol Head Neck Surg; 1992 Jan; 118(1):41-8. PubMed ID: 1370199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A phase 2 study of recombinant interleukin 2 (S-6820) for head and neck cancer].
    Sawaki S
    Gan No Rinsho; 1990 Feb; 36(2):111-20. PubMed ID: 2308207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
    Whiteside TL; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson JT; Myers E; Herberman RB
    Cancer Res; 1993 Dec; 53(23):5654-62. PubMed ID: 8242620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
    de Gast GC; Klümpen HJ; Vyth-Dreese FA; Kersten MJ; Verra NC; Sein J; Batchelor D; Nooijen WJ; Schornagel JH
    Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of unresectable recurrent head and neck carcinoma with 13-cis-retinoic acid and interferon-alpha. A phase II study.
    Nikolaou AC; Fountzilas G; Daniilidis I
    J Laryngol Otol; 1996 Sep; 110(9):857-61. PubMed ID: 8949297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin, 5-fluorouracil and interferon alpha 2b for recurrent or metastatic head and neck cancer.
    Cascinu S; Fedeli A; Luzi Fedeli S; Catalano G
    Br J Cancer; 1994 Feb; 69(2):392-3. PubMed ID: 8297740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and immune modulatory effects of alternative weekly interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma and melanoma.
    Pichert G; Jost LM; Fierz W; Stahel RA
    Br J Cancer; 1991 Feb; 63(2):287-92. PubMed ID: 1997108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Hussain M; Benedetti J; Smith RE; Rodriguez GI; Schuller D; Ensley J
    Cancer; 1995 Oct; 76(7):1233-7. PubMed ID: 8630903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive recombinant interleukin-2 and alpha-interferon therapy in patients with advanced head and neck squamous carcinoma.
    Urba SG; Forastiere AA; Wolf GT; Amrein PC
    Cancer; 1993 Apr; 71(7):2326-31. PubMed ID: 8453554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer.
    Jayson GC; Middleton M; Lee SM; Ashcroft L; Thatcher N
    Br J Cancer; 1998 Aug; 78(3):366-9. PubMed ID: 9703284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck.
    Vlock DR; Johnson J; Myers E; Day R; Gooding WE; Whiteside T; Pelch K; Sigler B; Wagner R; Colao D
    Head Neck; 1991; 13(1):15-21. PubMed ID: 1989925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
    Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK
    J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I-II trial of recombinant interferon alpha-2b with cisplatin and 5-fluorouracil in recurrent and/or metastatic carcinoma of head and neck.
    Bensmaine ME; Azli N; Domenge C; Armand JP; Cvitkovic E
    Am J Clin Oncol; 1996 Jun; 19(3):249-54. PubMed ID: 8638535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-alpha in patients with advanced head and neck squamous cell carcinoma.
    Gravis G; Pech-Gourgh F; Viens P; Alzieu C; Camerlo J; Oziel-Taieb S; Jausseran M; Maraninchi D
    Anticancer Drugs; 1999 Apr; 10(4):369-74. PubMed ID: 10378671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination nonviral cytokine gene therapy for head and neck cancer.
    Li D; Zeiders JW; Liu S; Guo M; Xu Y; Bishop JS; O'Malley BW
    Laryngoscope; 2001 May; 111(5):815-20. PubMed ID: 11368072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer. Five-year results with impressive complete response rates and high survival.
    Slotman GJ; Doolittle CH; Glicksman AS
    Cancer; 1992 Jun; 69(11):2736-43. PubMed ID: 1571903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled interleukin-2 in combination with low-dose systemic interleukin-2 and interferon alpha in patients with pulmonary metastatic renal-cell carcinoma: effectiveness and toxicity of mainly local treatment.
    Huland E; Heinzer H; Huland H
    J Cancer Res Clin Oncol; 1994; 120(4):221-8. PubMed ID: 8288676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.